Clinical Trials Browser

Phase 2 × Pancreatic Ductal Adenocarcinoma × devimistat × Clear all

NCT03374852 2025-04-29

CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Ductal Adenocarcinoma